Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer

被引:56
作者
Gil-Rendo A. [1 ]
Hernández-Lizoain J.L. [1 ]
Martínez-Regueira F. [1 ]
Sierra Martínez A. [1 ]
Rotellar Sastre F. [1 ]
Delgado M.C. [1 ]
Azcarate V.V. [1 ]
Idoate C.P. [1 ]
Álvarez-Cienfuegos J. [1 ]
机构
[1] General Surgery Department, Clinica Universitaria of Navarra, Pamplona, 31008 Pamplona Navarra
关键词
Gastric cancer; Risk factors for complications; Surgical morbidity and mortality;
D O I
10.1007/s12094-006-0182-x
中图分类号
学科分类号
摘要
Introduction: The purpose of this study is to analyze postoperative morbidity and mortality of patients operated on for gastric cancer in a single institution during the last twenty years, and to define risk factors for complications. Material and methods: A retrospective study was carried out on 434 patients who underwent gastrectomy for gastric cancer between January 1983 and December 2002. Analysis of main medical and surgical complications and analysis of morbidity risk factors. Results: Overall morbidity and mortality rates were 38.4% and 2.7% respectively. The most frequent complications were pneumonia (13%) and intra-abdominal abcesses (12%). The main cause of death was anastomotic dehiscence with abdominal sepsis. The last ten years mortality rate dropped from 4.7% to 0.8%. Risk factors for complications were gender (male, p = 0.01) and resection of spleen (p = 0.02) or pancreas (p = 0.002). A significantly lesser rate of complications was found in patients who had underwent gastrectomy during the previous five years (p = 0.001) or with tumors located in the lower third of the stomach (p = 0.01). Conclusion: Morbidity of gastrectomy for gastric cancer in our institution is still high but mortality has decreased significantly over the last ten years due to the specialization of the hospital and the surgical team. The main risk factor for complications was pancreatosplenectomy in the multivariate analysis. © FESEO 2006.
引用
收藏
页码:354 / 361
页数:7
相关论文
共 32 条
[21]  
Viste A., Svanes K., Janssen Jr. C.W., Maartmann-Moe H., Soreide O., Prognostic importance of radical lymphadenectomy in curative resections for gastric cancer, Eur J Surg., 160, 9, pp. 497-502, (1994)
[22]  
Otsuji E., Toma A., Kobayashi S., Cho H., Et al., Long-term benefit of extended lymphadenectomy with gastrectomy in distally located early gastric carcinoma, Am J Surg., 180, 2, pp. 127-132, (2000)
[23]  
Adachi Y., Mimori K., Mori M., Maehara Y., Sugimachi K., Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma, J Am Coll Surg., 184, 3, pp. 240-244, (1997)
[24]  
Robertson C.S., Chung S.C., Woods S.D., Et al., A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer, Ann Surg., 220, 2, pp. 176-182, (1994)
[25]  
Sendler A., Etter M., Bottcher K., Siewert J.R., Extent of resection in surgery of stomach carcinoma, Chirurg., 73, 4, pp. 316-324, (2002)
[26]  
Sierra A., Reguera F.M., Hernandez-Lizoain J.L., Pardo F., Martinez-Gonzalez M.A., Alvarez-Cienfuegos J., Role of the extended lymphadenectomy in gastric cancer surgery: Experience in a single institution, Ann Surg Oncol., 10, 3, pp. 219-226, (2003)
[27]  
Lewis W.G., Edwards P., Barry J.D., Et al., D2 or not D2? The gastrectomy question, Gastric Cancer, 5, 1, pp. 29-34, (2002)
[28]  
Meyer H.J., The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer, Eur J Surg Oncol., 51, 6, pp. 595-604, (2005)
[29]  
Diaz de Liano A., Ciga M.A., Oteiza F., Aizcorbe M., Cobo F., Trujillo R., Factors involved in morbidity and mortality of total gastrectomy for gastric cancer, Rev Oncol., 4, 5, pp. 265-270, (2002)
[30]  
Shchepotin I.B., Evans S.R., Chorny V.A., Shabahang M., Buras R.R., Nauta R.J., Postoperative complications requiring relaparotomies after 700 gastretomies performed for gastric cancer, Am J Surg., 171, 2, pp. 270-273, (1996)